Extracorporeal Shockwave Therapy in the Treatment of Peyronie's Disease
Trial Parameters
Brief Summary
Investigation of the effectiveness of extracorporeal shock wave therapy in the treatment of Peyronie's disease.
Eligibility Criteria
Inclusion Criteria: * Male individuals aged 18-65 years. * Having been diagnosed with Peyronie's Disease that has been stable (without increasing pain and curvature) for at least 6 months. * Presence of palpable penile plaque. Exclusion Criteria: * Acute inflammatory stage (painful, progressive) * Having previously undergone surgery, needle therapy (e.g., Xiaflex), or Extracorporeal Shockwave Therapy for peyronie's disease. * Uncontrolled diabetes, severe coagulopathy, or receiving anticoagulant therapy. * History of penile cancer. * Severe erectile dysfunction. * Patients who are considered unable to comply with the study protocol or who cannot attend follow-up visits.